Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer
| dc.contributor.author | Basaran, Gul A. | |
| dc.contributor.author | Twelves, Chris | |
| dc.contributor.author | Dieras, Veronique | |
| dc.contributor.author | Cortes, Javier | |
| dc.contributor.author | Awada, Ahmad | |
| dc.date.accessioned | 2025-10-16T15:25:53Z | |
| dc.date.issued | 2018 | |
| dc.identifier.doi | 10.1016/j.ctrv.2017.12.002 | |
| dc.identifier.other | WOS:000425562600014 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/8315 | |
| dc.publisher | ELSEVIER SCI LTD | |
| dc.source | CANCER TREATMENT REVIEWS | |
| dc.subject | Metastatic breast cancer | |
| dc.subject | Estrogen receptor\\-positive | |
| dc.subject | HER2\\-breast cancer | |
| dc.subject | Unmet needs | |
| dc.subject | Palbociclib | |
| dc.title | Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer | |
| dc.type | Review |
